Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial. Warren RA, Carew AS, Andreou P, Herman C, et al. Diabetes Care 2022;45:241-250.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Warren RA, Carew AS, Andreou P, Herman C, et al. Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial. Diabetes Care 2022;45:241-250.
PMID: 34785535